logo

SNOA

Sonoma Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)

SNOA fundamentals

Sonoma Pharmaceuticals (SNOA) released its earnings on Aug 7, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 7, 2025
EPS
Revenue

Revenue & Expenses

SNOA has released its 2026 Q2 earnings report, with revenue of 5.60M, reflecting a YoY change of 56.58%, and net profit of -534.00K, showing a YoY change of 12.46%. The Sankey diagram below clearly presents SNOA's revenue sources and cost distribution.

Key Indicators

Sonoma Pharmaceuticals (SNOA) key financial stats and ratios, covering profitability, financial health, and leverage.
Sonoma Pharmaceuticals (SNOA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Sonoma Pharmaceuticals (SNOA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Sonoma Pharmaceuticals (SNOA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Sonoma Pharmaceuticals (SNOA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Sonoma Pharmaceuticals (SNOA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield